Glenn Gould, DO
Family Medicine · Morganton, NCNPI 1164469011
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,473 of the $2,047 with a category attached, or 72.0%. Amgen accounts for 92.1% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,885, more than ten times the $67 reported in 2019.
Across 14 payments — averaging $146.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Novo Nordisk$44
- Johnson & Johnson$38
- Medtronic$37
- Merck$16
- Baxter Healthcare$15
- plus $13 from 1 others
Across 36 payments — averaging $14,933 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$214K
- AstraZeneca$146K
- Amgen$63K
- Regeneron$37K
- Genentech, Inc.$36K
- Astrazeneca UK Limited$30K
- plus $13K from 2 others
What the payments were for
- Travel & lodging$1,47372%
- Food & beverage$55927%
- Other$151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 6 | $1,885 |
| Novo Nordisk | 2 | $44 |
| Johnson & Johnson | 1 | $38 |
| Medtronic | 2 | $37 |
| Merck | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$2,047 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 79 | $84,826 |
| EliquisApixaban | 87 | $73,941 |
| Tresiba Flextouch U-100Insulin Degludec | 57 | $36,978 |
| JardianceEmpagliflozin | 26 | $25,362 |
| TrulicityDulaglutide | 17 | $23,456 |
| Repatha SyringeEvolocumab | 16 | $13,230 |
| FarxigaDapagliflozin Propanediol | 13 | $9,133 |
| SynthroidLevothyroxine Sodium | 77 | $7,178 |
| Humalog Kwikpen U-100Insulin Lispro | 17 | $5,120 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 22 | $4,897 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $4,567 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,281 |
| Semglee (Yfgn) PenInsulin Glargine-Yfgn | 11 | $4,181 |
| Omeprazole | 233 | $3,384 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 34 | $3,284 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $44 | $84,82679 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Morganton
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.